{
  "trial_id": "NCT00966498",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Patients diagnosed with high risk recurrent or refractory solid tumors following initial chemotherapy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Tumor must be sensitive to chemotherapy (maximum 8 cycles) and/or radiation defined as a greater than 50% reduction in size of the primary and/or metastatic sites.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients who are under 35 years of age.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients with a life expectancy of at least 8 weeks and performance status (Karnofsky or Lansky score) of at least 70%.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients who are acceptable candidates for peripheral blood stem cell transplantation based on their pre-transplant evaluation.",
      "label": "not_met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients will not be excluded based on sex, race.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients with central nervous system tumors are not eligible for this protocol.",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Patients have significant functional deficits in major organs which would interfere with successful outcome following PBSCT.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has a history of digestive issues and her husband was recently diagnosed with colon cancer, but she does not meet the exclusion criteria for CNS tumors or previous stem cell transplant.",
  "_meta": {
    "topic_id": "34",
    "trial_id": "NCT00966498",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}